These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26663224)

  • 1. A combination of the neutrophil-to-lymphocyte ratio and the GRACE risk score better predicts PCI outcomes in Chinese Han patients with acute coronary syndrome.
    Zhou D; Wan Z; Fan Y; Zhou J; Yuan Z
    Anatol J Cardiol; 2015; 15(12):995-1001. PubMed ID: 26663224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-to-Lymphocyte Ratio Improves the Predictive Power of GRACE Risk Score for Long-Term Cardiovascular Events in Patients with Acute Coronary Syndrome.
    Zhou D; Fan Y; Wan Z; Wen W; Wang X; Zhou J; Chen T; Yuan Z
    Cardiology; 2016; 134(1):39-46. PubMed ID: 26866504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao N; Mi L; Liu X; Pan S; Xu J; Xia D; Liu Z; Zhang Y; Xiang Y; Yuan Z; Guan G; Wang J
    PLoS One; 2015; 10(10):e0140532. PubMed ID: 26468876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of mean platelet volume and the GRACE risk score better predicts future cardiovascular events in patients with acute coronary syndrome.
    Wan ZF; Zhou D; Xue JH; Wu Y; Wang H; Zhao Y; Zhu L; Yuan ZY
    Platelets; 2014; 25(6):447-51. PubMed ID: 24102371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the ratio of neutrophil/lymphocyte and risk stratification, prognosis in patients with non-ST-elevation acute coronary syndrome].
    Wang Y; Jia SJ; Chi Z
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1784-1789. PubMed ID: 28647999
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio predicts coronary artery lesion complexity and mortality after non-ST-segment elevation acute coronary syndrome.
    Soylu K; Gedikli Ö; Dagasan G; Aydin E; Aksan G; Nar G; İnci S; Yilmaz Ö
    Rev Port Cardiol; 2015; 34(7-8):465-71. PubMed ID: 26164277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved predictive value of GRACE risk score combined with platelet reactivity for 1-year cardiovascular risk in patients with acute coronary syndrome who underwent coronary stent implantation.
    Li S; Liu H; Liu J; Wang H
    Platelets; 2016 Nov; 27(7):650-657. PubMed ID: 27809713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive value of GRACE discharge score for long-term out-of-hospital death in acute coronary syndrome after percutaneous coronary intervention].
    Zhao XY; Li JX; Tang XF; Xu JJ; Song Y; Wang HH; Xu LJ; Chen J; Zhang Y; Song L; Gao LJ; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(7):496-501. PubMed ID: 29495217
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.
    Bai XF; Zhang YP; Zhou J; Wu Y; Li RF; Sun LZ; Ma QQ; Lou BW; Zhai BW; Liu MP; Cheng LL; Tong XN; Yuan ZY
    Thromb Res; 2018 Oct; 170():142-147. PubMed ID: 30193195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with 30-day Major Adverse Cardiovascular Event in Acute Coronary Syndrome Patients with Non-Dialysis Chronic Kidney Disease: A Retrospective Cohort Study.
    Ginanjar E; Hustrini NM; Mansjoer A; Al Hanif MS
    Acta Med Indones; 2023 Jan; 55(1):10-18. PubMed ID: 36999254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Verdoia M; Nardin M; Gioscia R; Negro F; Marcolongo M; Suryapranata H; Kedhi E; De Luca G;
    Vascul Pharmacol; 2020 Sep; 132():106765. PubMed ID: 32681888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of the GRACE discharge score on the long-term out-of-hospital coronary thrombotic events after implantation of drug-eluting stents].
    Zhao XY; Li JX; Tang XF; Xian Y; Xu JJ; Song Y; Jiang L; Xu LJ; Chen J; Zhang Y; Song L; Gao LJ; Gao Z; Zhang J; Wu Y; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):187-191. PubMed ID: 29562422
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
    Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
    Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.
    Jakimov T; Mrdović I; Filipović B; Zdravković M; Djoković A; Hinić S; Milić N; Filipović B
    Croat Med J; 2017 Dec; 58(6):406-415. PubMed ID: 29308832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil count improves the GRACE risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    Zhang S; Wan Z; Zhang Y; Fan Y; Gu W; Li F; Meng L; Zeng X; Han D; Li X
    Atherosclerosis; 2015 Aug; 241(2):723-8. PubMed ID: 26132283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
    Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
    Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI.
    Qin Z; Xu S; Yuan R; Wang Z; Lu Y; Xu Y; Lv Y; Yu F; Bai J; Zhang H; Zhang L; Zhang J; Tang J
    Diabetes Metab Syndr Obes; 2022; 15():3015-3025. PubMed ID: 36196143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of inflammation-based Glasgow prognostic score, platelet-lymphocyte ratio, and global registry of acute coronary events score for major cardiovascular and cerebrovascular events during hospitalization in patients with acute myocardial infarction.
    Xu X; Cai L; Chen T; Ding S; Zhang F; Gao B; Zhu H; Huang J
    Aging (Albany NY); 2021 Jul; 13(14):18274-18286. PubMed ID: 34270463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.